Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 60 mg and 40 mg doses of hyoscine butylbromide on labor outcomes
TCTR20180123004Completed
- Sponsor
- Anthony Wanjala, David Kaihura, Benjamin Chemwolo, Kays Muruka
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of hyoscine butylbromide in childbirth (2 arms), sponsored by Anthony Wanjala, David Kaihura, Benjamin Chemwolo, Kays Muruka. Started Jan 2014; status: completed.
02
Drugs
hyoscine butylbromide
03
Conditions
childbirth
Beyond the preview
Go deeper on TCTR20180123004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180123004.